Sign in to view content

Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration

Justis P. Ehlers, MD, FASRS

Video
Published 2020

Related

Elamipretide, a Mitochondrial-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with High Risk Drusen
Michael J Allingham, MD, PhD
Annual Meeting Talks
2019
Performance and Usability of a Self-Operated Home Opctical Coherence Tomography (OCT) System: NOTAL-OCT V2.5 (NOV2.5)
Judy E. Kim, MD, FASRS
Updates from the Field
2019
Dual Anti-platelet Therapy Decelerates the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Yodpong Chantarasorn, MD
On Demand Cases, Courses, and Papers
2021

Category: AMD-Non-Neovascular

See more